State high courts are shaping opioid insurance lawsuits by ruling that standard business liability policies do not cover government claims for economic losses. Drug distributors, pharmacies and retailers must therefore pay their own legal defense and settlements in most opioid cases.
Commercial general liability insurance, often called CGL, is the standard business policy at issue. It covers damages because of bodily injury or property damage. Courts are deciding whether opioid lawsuits seek that type of damage.
Table of Contents
- Why insurers are winning coverage fights
- How far Delaware extended the rule
- Where the insurer-friendly trend breaks
- What does this mean for settlement money?
- What remains unresolved for Walmart
Why insurers are winning coverage fights
The Ohio Supreme Court held 5-2 in Acuity v. Masters Pharmaceutical that Acuity owed no duty to defend a drug distributor sued by cities and counties. According to Court News Ohio, government claims for economic losses are not damages because of bodily injury, as described in the Sept.
7, 2022 decision summary. The Delaware Supreme Court reached the same result in ACE American v. Rite Aid. According to LexBlog Insurance Law Hawaii analysis, insurers had no duty to defend where two Ohio counties sought only their own economic damages and disclaimed personal-injury damages, as explained in the March 14, 2022 coverage analysis.
How far Delaware extended the rule
Delaware then applied the Rite Aid rule to much larger pharmacy litigation. Its high court unanimously ruled that AIG, Chubb and other CGL insurers owed CVS Health no defense or indemnity for thousands of suits by governments, hospitals and payors.
According to Carrier Management, those suits sought economic losses rather than specific individualized bodily injury or property damage, as reported in the Aug. 19, 2025 case report. Delaware later extended that reasoning to grocer-pharmacy Albertsons in public-nuisance opioid suits.
Where the insurer-friendly trend breaks
An Arkansas appeals court split from that trend in an October 2026 Walmart case. It held that Walmart's primary and excess insurers must defend Walmart because the underlying suits potentially allege an accident and damages because of bodily injury.
That decision turns on the broader duty to defend. A duty to defend asks only whether a suit might fall within coverage. It does not decide the narrower duty to pay the final settlement or judgment.
What does this mean for settlement money?
These rulings decide who pays litigation costs, not who qualifies for compensation. For readers tracking class action settlements, the key effect is practical.
According to SDV Fenchurch, insurers now file Delaware declaratory-judgment actions to confirm they owe no defense or payment, forcing distributors, pharmacies and retailers to fund opioid defense and settlements themselves, as outlined in the Top 10 Insurance Cases of 2025. That pressure can affect how settlement funds flow:.
- Watch the defendant company, not its insurer, for payment updates.
- Track official settlement administrators for filing instructions and deadlines.
- Save pharmacy, medical and payment records tied to a specific settlement.
- Do not send personal information to a law firm advertisement without a verified case notice.
What remains unresolved for Walmart
The Walmart exception is limited. According to Arkansas Business, it addresses only defense costs and leaves unresolved whether insurers must indemnify Walmart's approximately $3.1 billion opioid settlement, as detailed in the Oct.
7, 2026 ruling report. That indemnity question is the largest payment issue. Until courts decide it, retailers face the same risk seen in Delaware: paying lawyers now while fighting insurers later over reimbursement.